Sector: MedicalNGSX (NASDAQ: NGSX)
Headlines
- NeurogesX to Present at Piper Jaffray Health Care Conference
Nov 24, 2009 10:30 AM | NGSX, PJC
- NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
Nov 24, 2009 09:02 AM | BIIB, JNJ, NGSX, OSIP
- NeurogesX to Hold Conference Call to Discuss FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
Nov 17, 2009 07:30 AM | NGSX
- NeurogesX (NASDAQ: NGSX) Receives FDA Approval For Qutenza
Nov 16, 2009 07:56 PM | NGSX
- NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
Nov 16, 2009 05:31 PM | NGSX
- NeurogesX Reports Third Quarter 2009 Results
Nov 06, 2009 07:30 AM | NGSX
- NeurogesX Expands Commercial Operations Leadership Team
Nov 05, 2009 08:31 AM | NGSX
- NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
Oct 30, 2009 08:31 AM | NGSX
- NeurogesX to Present at Two November Conferences
Oct 29, 2009 08:31 AM | NGSX
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM | ACCP, APOL, CLDA, CRI, CRL, CYTX
- NeurogesX Appoints New Board Director and Audit Committee Chairman
Aug 25, 2009 08:31 AM | NGSX
- NeurogesX Reports Second Quarter 2009 Results
Aug 07, 2009 07:53 AM | NGSX
- NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
Aug 05, 2009 05:35 PM | NGSX
- NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
Jul 31, 2009 09:01 AM | NGSX
- NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
Jul 24, 2009 09:02 AM | NGSX
- NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
Jul 17, 2009 04:02 PM | NGSX
- NeurogesX Added to Russell 3000 Index
Jun 29, 2009 08:02 AM | NGSX
- NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
Jun 22, 2009 07:01 AM | NGSX
- NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
Jun 10, 2009 09:01 AM | NGSX
- NeurogesX to Present at Needham Life Sciences Conference
Jun 03, 2009 09:03 AM | NGSX
- Form 4 NeurogesX Inc For: Nov 19 Filed by: Orwin John A (10K)
Nov 23, 2009 07:21 PM
- Form 3 NeurogesX Inc For: Nov 19 Filed by: Orwin John A (10K)
Nov 23, 2009 07:15 PM
- Form 4 NeurogesX Inc For: Nov 19 Filed by: Rinne Susan P (10K)
Nov 23, 2009 02:19 PM
- Form 4 NeurogesX Inc For: Nov 19 Filed by: BIENAIME JEAN JACQUES (10K)
Nov 23, 2009 02:17 PM
- Form 4 NeurogesX Inc For: Oct 15 Filed by: NELSEN ROBERT (10K)
Oct 19, 2009 07:56 PM
- Form 4 NeurogesX Inc For: Oct 15 Filed by: Kurtz Neil M (10K)
Oct 19, 2009 07:54 PM
- Form 4 NeurogesX Inc For: Oct 15 Filed by: BIENAIME JEAN JACQUES (10K)
Oct 19, 2009 07:54 PM
- Form 4 NeurogesX Inc For: Sep 15 Filed by: SV LIFE SCIENCES FUND IV LP (10K)
Sep 17, 2009 05:58 PM
- Form 4 Goodwin Bradford S For: Aug 20 (10K)
Aug 24, 2009 08:04 PM
- Form 3 Goodwin Bradford S For: Aug 20 (10K)
Aug 24, 2009 07:44 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
NGSX
|
Compare to S&P
|
| YTD |
622.22 %
|
497.73 %
|
| 4 Weeks |
10.03 %
|
8.84 %
|
| 12 Weeks |
11.33 %
|
4.96 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -22.58 %
|
|
EPS Growth in Last Year: -5.56 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
